Parsel Plus (reference US product: Excedrin Tension Headache) (Acetaminophen 500 mg and Caffeine...

FDA Drug Recall #D-846-2013 — Class II — June 6, 2013

Recall Summary

Recall Number D-846-2013
Classification Class II — Moderate risk
Date Initiated June 6, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Novartis Consumer Health
Location Lincoln, NE
Product Type Drugs
Quantity 472,000 pouches

Product Description

Parsel Plus (reference US product: Excedrin Tension Headache) (Acetaminophen 500 mg and Caffeine 65 mg), packaged in 2-count pouches, Distributed by Novartis Consumer Health, Inc., USA and Novartis Consumer Health S.A., Brazil, for Novartis de Venezuela. The foreign packaging do not have NDC number This product was only distributed to Novartis Brazil by the recalling firm

Reason for Recall

Defective container: products are packaged in pouches which may not have been fully sealed

Distribution Pattern

Nationwide, Puerto Rico, Brazil and Panama

Lot / Code Information

Lot # 10121996, Exp 7/13

Other Recalls from Novartis Consumer Health

Recall # Classification Product Date
D-022-2014 Class III Loratadine, USP 10 mg, Antihistamine, packaged ... Sep 3, 2013
D-909-2013 Class III Maalox Nighttime Antacid with Acid Reflux Barri... Aug 6, 2013
D-910-2013 Class III Maalox Nighttime Antacid with Acid Reflux Barri... Aug 6, 2013
D-907-2013 Class III Maalox, Regular Strength Antacid (calcium carbo... Aug 6, 2013
D-902-2013 Class III Maalox Extra Strength Antacid with Anti-Gas (ca... Aug 6, 2013

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.